OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
July 23, 2020
Dr. Geeta Vemuri, founder of biopharma investment firm Agent Capital, talks about sustaining a career in the venture capital sector.
July 21, 2020
In adjusting to the long-term side-effects of the coronavirus pandemic, pharma companies will need to focus on change in three areas. Ben van der Schaaf and Aurelien Guichard report.
Immunomedics’ CFO/CBO Usama Malik discusses how a lot of good planning and a little good fortune helped the company to achieve its “virtual launch” amid the coronavirus crisis.
July 20, 2020
In recent months, many pharma businesses have pivoted to entirely new product lines against a backdrop of unprecedented disruption to the supply chain. Gurdip Singh provide pointers to ensure companies are ready to adapt to change.
July 09, 2020
Our 20th annual listing highlights brand surges, new ranking battles, and M&A-sparked upswings, but in the shadow of COVID-19, a peek behind the numbers also tells another story.
July 08, 2020
How COVID-19 has changed high-level recruitment.
July 07, 2020
Three areas critical to ensuring meaningful long-term action.
July 06, 2020
The transition from in-person was challenging, but meetings like DIA’s global event could explore formal hybrid models in the future.
July 01, 2020
Case study illustrates how compliance teams, in today’s climate, can foster innovation across an organization to help achieve corporate goals.
June 26, 2020
Xavier Duburcq describes how pharma leaders can convert compliance from a cost center to a critical success factor.